Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2025

Aug 18, 2025

33003_dirs_2025-08-18_9dea58c7-61bf-4dfb-b5f8-0f225679323a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2025-08-14

Reporting Person: Tan Kevin (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-08-14 Employee Stock Option (Right to Buy) $6.17 A 125000 Acquired 2035-08-14 Common Stock (125000) Direct
2025-08-14 Restricted Stock Units $ A 62500 Acquired Common Stock (62500) Direct

Footnotes

F1: The RSUs (as defined in footnote 2) together with this option were granted on August 14, 2025 (the "Grant Date") and vest over four years, with 50% of the original number of shares vesting on the second anniversary of the Grant Date and 25% of the original number of shares annually thereafter until the fourth such anniversary.

F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").